Embedded Files
Reversing Insulin Resistance & Restoring Pancreatic Function
Targeting the Root Cause of Metabolic Decline
Traditional diabetes management focuses on managing symptoms through lifelong daily medication or insulin injections. Our advanced cellular management protocols target the actual biological root causes: chronic metabolic inflammation and pancreatic tissue degeneration.
By introducing specialized, high-viability mesenchymal stem cells (MSCs), we aim to systematically reset your body's glucose metabolism environment, allowing damaged organs to heal from within.
1. Reversing Insulin Resistance
Stem cells systemic suppress the chronic, low-grade inflammation in fat, liver, and muscle tissues, reactivating dormant insulin receptors and drastically improving cellular glucose uptake.
2. Protecting & Repairing Pancreatic Islets
Through powerful paracrine signaling, the introduced cells secrete critical growth factors that protect surviving pancreatic beta cells from apoptosis (cell death) and stimulate localized tissue regeneration.
3. Preventing Vascular Complications
Diabetes causes severe long-term damage to microvessels. Cellular therapy accelerates endothelial cell repair, restores systemic vascular elasticity, and lowers the risk of diabetic neuropathy and cardiovascular complications.
The Power of the National Medical Pilot Zone: Absolute Legal Compliance
Exclusive Sovereign Privileges for Advanced Medicine
ANHE INTERNATIONAL proudly operates within China’s sole national-level medical pilot zone—a visionary healthcare sanctuary established by the State Council. This exclusive designation grants us unique, legally sanctioned "先行先试" (First-to-Try) privileges. Here, cutting-edge cellular therapies, international-standard clinical protocols, and next-generation biomedical products are legally approved for patient care years before they become available in the rest of the country.
Every protocol is fully authorized by institutional review boards and processed within state-of-the-art, certified GMP laboratories, ensuring absolute legal protection, international-grade cell viability, and zero contamination.
Backed by Global Scientific & Clinical Consensus
The therapeutic potential of stem cell medicine is documented in the world’s most prestigious peer-reviewed medical journals. Our clinical protocols align with the breakthroughs published in:
The Lancet & Nature Medicine: Extensive international publications demonstrate that mesenchymal stem cells (MSCs) effectively suppress chronic metabolic inflammation, offering a groundbreaking pathway for reversing insulin resistance.
PubMed / NIH National Library of Medicine: Over tens of thousands of registered clinical trials globally validate the safety, high tolerability, and structural regenerative efficacy of targeted cellular therapeutics for metabolic disorders.
Science & Cell Stem Cell: Global landmark studies confirm that cellular therapeutics successfully rescue dysfunctional islet cells and promote multi-organ metabolic homeostasis.
ANHE INTERNATIONAL
☎️Whatsapp：0086 183 9687 6961
🏥Address：Boao Lecheng Pilot Zone, Qionghai City, Hainan Province, China
Google Sites
Report abuse